文献速递脑血管病

纤维蛋白凝块通透性预测房颤抗凝患者卒中与出血

Fibrin Clot Permeability as a Predictor of Stroke and Bleeding in Anticoagulated Patients With Atrial Fibrillation.
PubMed 文献 · Stroke · 2017-09-13

本研究为纵向队列研究,纳入236例接受维生素K拮抗剂治疗的房颤患者,检测血浆纤维蛋白凝块通透性(Ks)。中位随访4.3年发现,低Ks(<6.8 cm2×10-9)与缺血性卒中/TIA及大出血风险显著增加独立相关,高Ks则与轻微出血增加相关。

要点

  • 低纤维蛋白凝块通透性(Ks<6.8 cm2×10-9)预测房颤抗凝患者缺血性卒中/TIA和大出血风险。
  • 高Ks(≥6.8 cm2×10-9)与轻微出血率升高相关。
  • 纤维蛋白凝块特性可能部分决定维生素K拮抗剂抗凝的疗效与安全性。

核心结论

  • 首次显示致密纤维蛋白网络形成所反映的不良纤维蛋白特性,部分决定房颤患者维生素K拮抗剂抗凝的疗效与安全性。

研究设计与样本

  • 纵向队列研究,纳入236例接受维生素K拮抗剂治疗的房颤患者,检测离体血浆纤维蛋白凝块通透性(Ks)。

主要发现

  • 中位随访4.3年(四分位距3.7-4.8年),缺血性卒中或短暂性脑缺血发作年发生率为2.96%,大出血年发生率为3.45%。
  • 多变量Cox回归中,低Ks(<6.8 cm2×10-9,中位数)患者缺血性卒中或短暂性脑缺血发作风险增加(HR 6.55;95%CI 2.17-19.82),大出血风险增加(HR 10.65;95%CI 3.52-32.22)。
  • 高Ks(≥6.8 cm2×10-9)患者轻微出血年发生率为11.63%,其余患者为3.55%(P<0.0001)。
  • 缺血性卒中或短暂性脑缺血发作的独立预测因素包括低Ks(HR 7.24;95%CI 2.53-20.76)、年龄(HR 1.05;95%CI 1.01-1.10)及血管紧张素转换酶抑制剂治疗(HR 2.27;95%CI 1.08-4.77)。
  • 大出血的预测因素包括低Ks(HR 8.48;95%CI 2.99-24.1)和HAS-BLED评分≥3(HR 2.22;95%CI 1.12-4.38)。

临床怎么用

  • 在房颤抗凝患者中,可考虑检测纤维蛋白凝块通透性以辅助评估卒中与出血风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Formation of denser fiber networks has been reported in atrial fibrillation and ischemic stroke. In this longitudinal cohort study, we evaluated whether fibrin clot density may predict thromboembolic and bleeding risk in patients with atrial fibrillation on vitamin K antagonists. METHODS: In 236 patients with atrial fibrillation receiving vitamin K antagonists treatment, we measured ex vivo plasma clot permeability (Ks), a measure of the pore size in fibrin networks. RESULTS: During a median follow-up of 4.3 (interquartile range, 3.7-4.8) years, annual rates of ischemic stroke or transient ischemic attack and major bleeds were 2.96% and 3.45%, respectively. In multivariate Cox regression analysis, patients with lower Ks (<6.8 cm2×10-9, median) had increased risk of ischemic stroke or transient ischemic attack (hazard ratio [HR], 6.55; 95% confidence interval [CI], 2.17-19.82) and major bleeds (HR, 10.65; 95% CI, 3.52-32.22). Patients with elevated Ks (≥6.8 cm2×10-9) had an increased rate of minor bleeding compared with the remainder (11.63% per year versus 3.55% per year; P<0.0001). The independent predictors of stroke or transient ischemic attack were low Ks (<6.8 cm2×10-9; HR, 7.24; 95% CI, 2.53-20.76), age (HR, 1.05; 95% CI, 1.01-1.10), and treatment with angiotensin-converting enzyme inhibitors (HR, 2.27; 95% CI, 1.08-4.77). Major bleeds were predicted by low Ks (<6.8 cm2×10-9; HR, 8.48; 95% CI, 2.99-24.1) and HAS-BLED score ≥3 (HR, 2.22; 95% CI, 1.12-4.38). CONCLUSIONS: This study is the first to show that unfavorable fibrin properties reflected by formation of denser fibrin networks determine, in part, the efficacy and safety of anticoagulation with vitamin K antagonists in patients with atrial fibrillation.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Drabik L, Wołkow P, Undas A, et al. Fibrin Clot Permeability as a Predictor of Stroke and Bleeding in Anticoagulated Patients With Atrial Fibrillation. Stroke. 2017. PMID: 28904234. doi:10.1161/STROKEAHA.117.018143

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。